Navigation Links
Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
Date:6/2/2008

SOUTH SAN FRANCISCO, Calif., June 2 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will host a conference call with simultaneous webcast to discuss the preliminary results of its Phase 2 clinical study of R788, a novel, oral Syk kinase inhibitor, in patients with B-cell non-Hodgkin's lymphomas on Tuesday, June 3, 2008 at 8:00 a.m. EDT. Participating on the call will be Rigel senior management and the principal investigator on the study, Jonathan Friedberg, M.D., M.S.Sc., Associate Professor of Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center.

Conference Call and Webcast Information

To access the live call, please dial 866-356-3095 (domestic) or 617-597-5391 (international) 10 minutes prior to the start time and use the passcode 61157501. A replay of the call will be available, in webcast and podcast formats, at approximately 10:00 a.m. EDT on June 3, 2008 until June 10, 2008. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and use the passcode 11043962. The conference call will also be webcast live and can be accessed from Rigel's website at http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.

Further information on R788 in B-cell lymphoma is available at Rigel's website: http://www.rigel.com/rigel/lymphoma.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that d
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
2. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
3. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
4. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
5. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
6. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
7. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
8. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
9. PRoFESS(R) Results Announced at XVII European Stroke Conference
10. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
11. Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015  EndoChoice Holdings, Inc. (NYSE:  GI) announced ... financial results on Thursday, August 6, 2015 before the ... conference call on Thursday, August 6, 2015 at 9:00 ... are (866) 807-9684 for domestic callers and (412) 317-5415 ... call will be available on the investor relations section ...
(Date:7/6/2015)... , July 6, 2015 Flower ... fixation concept the FlowerCube™, announced today that it ... the opportunity for significant expansion of the innovative ... The approval encompasses Flower Orthopedics, entire product ... for upper and lower extremities. Consisting of more ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/bkw8kk/pharmaceutical ) has ... in North America 2015-2019" report to their offering. ... North America to grow at a CAGR ... International regulations regarding safe drug delivery are enforced by ... adoption of sustainable packaging. Various raw materials such as ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2Flower Orthopedics cleared to enter the European Union 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3
... The Chinese Biopharmaceutical Association-USA (CBA) successfully held its 16 ... US.   With the theme of ... the conference drew nearly 500 attendees with ... exhibited at the conference, including Chinese leading biotech parks, ...
... The Council on Competitiveness, in partnership with the ... case study today highlighting the potential for high performance ... facing the health care industry. The report, " ... the Delivery of ,Smarter, Health Care ," studies ...
Cached Medicine Technology:Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference 2Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference 3Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare 2
(Date:7/7/2015)... ... July 07, 2015 , ... Office ... the company’s new Chief Financial Officer, effective July 6th, 2015. Ellen joins Office ... ranging from a multi-billion dollar, global chemical company to early and growth-stage technology ...
(Date:7/7/2015)... Colo. (PRWEB) , ... July ... ... landscape relies on highly educated and motivated leaders with strong managerial expertise ... well they clearly communicate with patients, staff, providers, business partners, insurance companies, ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... management solutions, has announced the release of Service Pack 5600 for its ... a number of enhancements to the already robust capabilities of the reporting ...
(Date:7/7/2015)... ... 2015 , ... On May 29, 2015, Health Canada announced that they had ... claims for gluten free oats and foods that contain them as ingredients. , “We ... (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, VP of Regulatory ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Connexion Point is holding an onsite job ... be held at 1769 Paragon Place, Suite 100, this upcoming Wednesday, July 8, and Thursday, ... fair, Connexion Point will be recruiting new applicants as well as holding onsite interviews. ...
Breaking Medicine News(10 mins):Health News:Office Practicum Announces new CFO 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2
... Gospel to foreign nations fulfilled his heart’s passion for ... in 1998, he experienced severe headaches that eventually forced ... relief for the Garland resident’s cluster headaches, which occurred ... in succession and caused facial throbbing, until he came ...
... high levels of lipoprotein(a), particularly those with high ... risk for cardiovascular events, according to a study ... ,Lipoprotein(a) is a specific class of lipoprotein ... low-density lipoprotein cholesterol (LDL-C), according to background information ...
... preeclamptic pregnancy has improved substantially over the last 35 ... stillbirths// and improvements in clinical management, according to a ... ,Preeclampsia (a potentially dangerous condition that may develop in ... fluid retention, excessive weight gain, and the presence of ...
... low-density lipid “bad” cholesterol and triglycerides, and slightly raises ... study published in the Sept. 1, 2006 issue of ... study gives strong support to the notion that soy ... for the prevention and treatment of high blood cholesterol ...
... hospitals have unearthed the use of tainted human body parts, ... 25 UK hospitals as implants for patients. This information came ... matters of public interest take precedence over issues of secrecy, ... ,This is thought to be the work of ...
... study, frequent short sessions of exercise may be more ... single long session one//. ,This study was ... published in the September issue of the Journal of ... over 80-89 mm Hg, it is a condition called ...
Cached Medicine News:Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 2Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 3Health News:High Levels of Lipoprotein(a) in Women is Associated With Cardiovascular Risk 2Health News:Improvement Seen in Fetal Survival Following Preeclampsia 2Health News:Stolen Body Parts From Human Cadavers used as Implants by 25 UK Hospitals 2
... SPECIFICATIONS Form: Granular, free-flowing powder EEO(-m r ): ... less than or equal to 35.5C Remelt Point ... Strength (1.5%): greater than or equal to 600 ... than or equal to 1500 gm/cm 2 Moisture: ...
... chloride (Cl) ≤ 5000 mg/kg sulfate (SO 4 ) ... Cd ≤ 5 mg/kg Co ≤ 5 mg/kg Cr ... 10 mg/kg K ≤ 50 mg/kg Mg ≤ 5 ... Ni ≤ 5 mg/kg Pb ≤ 5 mg/kg Zn ...
Inquire...
Inquire...
Medicine Products: